NCT01152996View on ClinicalTrials.gov

Safety and Tolerability of Vortioxetine (LuAA21004) - Open Label Extension Study

PHASE3CompletedINTERVENTIONAL

Enrollment

1,075

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions

Depressive Disorder, Major

Interventions

DRUG

Vortioxetine

Vortioxetine tablets

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY